Alkem Laboratories Balance Sheet Health
Financial Health criteria checks 6/6
Alkem Laboratories has a total shareholder equity of ₹102.2B and total debt of ₹14.4B, which brings its debt-to-equity ratio to 14.1%. Its total assets and total liabilities are ₹149.3B and ₹47.0B respectively. Alkem Laboratories's EBIT is ₹19.2B making its interest coverage ratio -23.2. It has cash and short-term investments of ₹36.1B.
Key information
14.1%
Debt to equity ratio
₹14.43b
Debt
| Interest coverage ratio | -23.2x |
| Cash | ₹36.10b |
| Equity | ₹102.25b |
| Total liabilities | ₹47.01b |
| Total assets | ₹149.26b |
Recent financial health updates
We Think Alkem Laboratories (NSE:ALKEM) Can Manage Its Debt With Ease
Dec 27
Is Alkem Laboratories (NSE:ALKEM) Using Too Much Debt?
Sep 14We Think Alkem Laboratories (NSE:ALKEM) Can Stay On Top Of Its Debt
Mar 27Does Alkem Laboratories (NSE:ALKEM) Have A Healthy Balance Sheet?
Dec 26These 4 Measures Indicate That Alkem Laboratories (NSE:ALKEM) Is Using Debt Reasonably Well
Sep 20Does Alkem Laboratories (NSE:ALKEM) Have A Healthy Balance Sheet?
May 23Recent updates
Alkem Laboratories Limited (NSE:ALKEM) Just Reported And Analysts Have Been Lifting Their Price Targets
Feb 13Investors Appear Satisfied With Alkem Laboratories Limited's (NSE:ALKEM) Prospects
Jan 17We Think Alkem Laboratories (NSE:ALKEM) Can Manage Its Debt With Ease
Dec 27Is Alkem Laboratories (NSE:ALKEM) Using Too Much Debt?
Sep 14Alkem Laboratories (NSE:ALKEM) Is Paying Out A Larger Dividend Than Last Year
Aug 02Alkem Laboratories (NSE:ALKEM) Is Paying Out A Larger Dividend Than Last Year
Jul 07Alkem Laboratories (NSE:ALKEM) Is Paying Out A Larger Dividend Than Last Year
May 22We Think Alkem Laboratories (NSE:ALKEM) Can Stay On Top Of Its Debt
Mar 27Does Alkem Laboratories (NSE:ALKEM) Have A Healthy Balance Sheet?
Dec 26These 4 Measures Indicate That Alkem Laboratories (NSE:ALKEM) Is Using Debt Reasonably Well
Sep 20Alkem Laboratories' (NSE:ALKEM) Dividend Is Being Reduced To ₹4.00
Jul 27Alkem Laboratories' (NSE:ALKEM) Shareholders Will Receive A Smaller Dividend Than Last Year
Jul 13Does This Valuation Of Alkem Laboratories Limited (NSE:ALKEM) Imply Investors Are Overpaying?
Jun 11Does Alkem Laboratories (NSE:ALKEM) Have A Healthy Balance Sheet?
May 23Does This Valuation Of Alkem Laboratories Limited (NSE:ALKEM) Imply Investors Are Overpaying?
Mar 06Does Alkem Laboratories (NSE:ALKEM) Have A Healthy Balance Sheet?
Feb 21Alkem Laboratories (NSE:ALKEM) Is Paying Out A Larger Dividend Than Last Year
Feb 08Should You Be Adding Alkem Laboratories (NSE:ALKEM) To Your Watchlist Today?
Jan 09Does This Valuation Of Alkem Laboratories Limited (NSE:ALKEM) Imply Investors Are Overpaying?
Nov 30Here's Why Alkem Laboratories (NSE:ALKEM) Can Manage Its Debt Responsibly
Nov 17I Built A List Of Growing Companies And Alkem Laboratories (NSE:ALKEM) Made The Cut
Sep 07Here's Why Alkem Laboratories Limited's (NSE:ALKEM) CEO May Deserve A Raise
Aug 20Alkem Laboratories (NSE:ALKEM) Is Increasing Its Dividend To ₹5.00
Aug 03Is Alkem Laboratories (NSE:ALKEM) Using Too Much Debt?
Jul 19Does This Valuation Of Alkem Laboratories Limited (NSE:ALKEM) Imply Investors Are Overpaying?
Jul 01Do Alkem Laboratories's (NSE:ALKEM) Earnings Warrant Your Attention?
May 25What Kind Of Investors Own Most Of Alkem Laboratories Limited (NSE:ALKEM)?
Mar 17Why Dividend Hunters Love Alkem Laboratories Limited (NSE:ALKEM)
Mar 04Alkem Laboratories Limited (NSE:ALKEM) Insiders Have Been Selling
Feb 19Do Alkem Laboratories's (NSE:ALKEM) Earnings Warrant Your Attention?
Feb 07Alkem Laboratories (NSE:ALKEM) Could Be A Buy For Its Upcoming Dividend
Feb 07Financial Position Analysis
Short Term Liabilities: ALKEM's short term assets (₹96.6B) exceed its short term liabilities (₹39.1B).
Long Term Liabilities: ALKEM's short term assets (₹96.6B) exceed its long term liabilities (₹7.9B).
Debt to Equity History and Analysis
Debt Level: ALKEM has more cash than its total debt.
Reducing Debt: ALKEM's debt to equity ratio has reduced from 18.9% to 14.1% over the past 5 years.
Debt Coverage: ALKEM's debt is well covered by operating cash flow (142.3%).
Interest Coverage: ALKEM earns more interest than it pays, so coverage of interest payments is not a concern.